Health
Johnson & Johnson Partners with Myeloma Ireland for ‘Rooted in Resilience’ garden at Bloom 2026
Johnson & Johnson has partnered with Myeloma Ireland as lead sponsor of the gold medal-winning ‘Rooted in Resilience’ garden at Bloom 2026.
Johnson & Johnson has partnered with Myeloma Ireland as lead sponsor of the gold medal-winning ‘Rooted in Resilience’ garden at Bloom 2026.
Johnson & Johnson has announced European approval for eligible multiple myeloma patients or caregivers to self-administer DARZALEX® from the fifth dose onwards.
Gilead Sciences and Kite have announced the reimbursement of two CAR T-cell therapies in Ireland for eligible adult patients with certain relapsed or refractory blood cancers.